B-intervention	0	11	Genetically
I-intervention	12	21	Predicted
I-intervention	22	26	Body
I-intervention	27	31	Mass
I-intervention	32	37	Index
O	38	41	and
O	42	48	Breast
O	49	55	Cancer
O	56	60	Risk
O	60	61	:
O	62	71	Mendelian
O	72	85	Randomization
O	86	94	Analyses
O	95	97	of
O	98	102	Data
O	103	107	from
B-total-participants	108	111	145
I-total-participants	111	112	,
I-total-participants	112	115	000
O	116	121	Women
O	122	124	of
B-ethinicity	125	133	European
O	134	141	Descent
O	141	142	.

O	143	156	Observational
O	157	172	epidemiological
O	173	180	studies
O	181	185	have
O	186	191	shown
O	192	196	that
O	197	201	high
O	202	206	body
O	207	211	mass
O	212	217	index
O	218	219	(
O	219	222	BMI
O	222	223	)
O	224	226	is
O	227	237	associated
O	238	242	with
O	243	244	a
O	245	252	reduced
O	253	257	risk
O	258	260	of
O	261	267	breast
O	268	274	cancer
O	275	277	in
O	278	291	premenopausal
O	292	297	women
O	298	301	but
O	302	304	an
O	305	314	increased
O	315	319	risk
O	320	322	in
O	323	337	postmenopausal
O	338	343	women
O	343	344	.

O	345	347	It
O	348	350	is
O	351	358	unclear
O	359	366	whether
O	367	371	this
O	372	383	association
O	384	386	is
O	387	395	mediated
O	396	403	through
O	404	410	shared
O	411	418	genetic
O	419	421	or
O	422	435	environmental
O	436	443	factors
O	443	444	.

O	445	447	We
O	448	455	applied
O	456	465	Mendelian
O	466	479	randomization
O	480	482	to
O	483	491	evaluate
O	492	495	the
O	496	507	association
O	508	515	between
O	516	519	BMI
O	520	523	and
O	524	528	risk
O	529	531	of
O	532	538	breast
O	539	545	cancer
O	546	556	occurrence
O	557	562	using
O	563	567	data
O	568	572	from
O	573	576	two
O	577	582	large
O	583	589	breast
O	590	596	cancer
O	597	606	consortia
O	606	607	.

O	608	610	We
O	611	618	created
O	619	620	a
O	621	629	weighted
O	630	633	BMI
O	634	641	genetic
O	642	647	score
O	648	658	comprising
O	659	661	84
O	662	665	BMI
O	665	666	-
O	666	676	associated
O	677	684	genetic
O	685	693	variants
O	694	696	to
O	697	706	predicted
O	707	710	BMI
O	710	711	.

O	712	714	We
O	715	724	evaluated
O	725	736	genetically
O	737	746	predicted
O	747	750	BMI
O	751	753	in
O	754	765	association
O	766	770	with
O	771	777	breast
O	778	784	cancer
O	785	789	risk
O	790	795	using
O	796	806	individual
O	806	807	-
O	807	812	level
O	813	817	data
O	818	822	from
O	823	826	the
O	827	833	Breast
O	834	840	Cancer
O	841	852	Association
O	853	863	Consortium
O	864	865	(
O	865	869	BCAC
O	869	870	)
O	871	872	(
O	872	877	cases
O	879	880	=
B-intervention-participants	882	884	46
I-intervention-participants	884	885	,
I-intervention-participants	885	888	325
O	888	889	,
B-control	890	898	controls
O	900	901	=
B-control-participants	903	905	42
I-control-participants	905	906	,
I-control-participants	906	909	482
O	909	910	)
O	910	911	.

O	912	914	We
O	915	922	further
O	923	932	evaluated
O	933	936	the
O	937	948	association
O	949	956	between
O	957	968	genetically
O	969	978	predicted
O	979	982	BMI
O	983	986	and
O	987	993	breast
O	994	1000	cancer
O	1001	1005	risk
O	1006	1011	using
O	1012	1019	summary
O	1020	1030	statistics
O	1031	1035	from
O	1036	1038	16
O	1038	1039	,
O	1039	1042	003
O	1043	1048	cases
O	1049	1052	and
O	1053	1055	41
O	1055	1056	,
O	1056	1059	335
O	1060	1068	controls
O	1069	1073	from
O	1074	1077	the
O	1078	1087	Discovery
O	1087	1088	,
O	1089	1096	Biology
O	1096	1097	,
O	1098	1101	and
O	1102	1106	Risk
O	1107	1109	of
O	1110	1119	Inherited
O	1120	1128	Variants
O	1129	1131	in
O	1132	1138	Breast
O	1139	1145	Cancer
O	1146	1147	(
O	1147	1152	DRIVE
O	1152	1153	)
O	1154	1161	Project
O	1161	1162	.

O	1163	1170	Because
O	1171	1175	most
O	1176	1183	studies
O	1184	1192	measured
O	1193	1196	BMI
O	1197	1202	after
O	1203	1209	cancer
O	1210	1219	diagnosis
O	1219	1220	,
O	1221	1223	we
O	1224	1229	could
O	1230	1233	not
O	1234	1241	conduct
O	1242	1243	a
O	1244	1252	parallel
O	1253	1261	analysis
O	1262	1264	to
O	1265	1275	adequately
O	1276	1284	evaluate
O	1285	1288	the
O	1289	1300	association
O	1301	1303	of
O	1304	1312	measured
O	1313	1316	BMI
O	1317	1321	with
O	1322	1328	breast
O	1329	1335	cancer
O	1336	1340	risk
O	1341	1354	prospectively
O	1354	1355	.

O	1356	1358	In
O	1359	1362	the
O	1363	1367	BCAC
O	1368	1372	data
O	1372	1373	,
O	1374	1385	genetically
O	1386	1395	predicted
O	1396	1399	BMI
O	1400	1403	was
O	1404	1409	found
O	1410	1412	to
O	1413	1415	be
O	1416	1425	inversely
O	1426	1436	associated
O	1437	1441	with
B-outcome	1442	1448	breast
I-outcome	1449	1455	cancer
I-outcome	1456	1460	risk
O	1461	1462	(
O	1462	1466	odds
O	1467	1472	ratio
O	1473	1474	[
O	1474	1476	OR
O	1476	1477	]
O	1479	1480	=
O	1482	1483	0
O	1483	1484	.
O	1484	1486	65
O	1487	1490	per
O	1491	1492	5
O	1493	1495	kg
O	1495	1496	/
O	1496	1498	m2
O	1499	1507	increase
O	1507	1508	,
O	1509	1511	95
O	1511	1512	%
O	1513	1523	confidence
O	1524	1532	interval
O	1533	1534	[
O	1534	1536	CI
O	1536	1537	]
O	1537	1538	:
O	1539	1540	0
O	1540	1541	.
O	1541	1543	56
O	1543	1544	-
O	1544	1545	0
O	1545	1546	.
O	1546	1548	75
O	1548	1549	,
O	1550	1551	p
O	1552	1553	=
O	1554	1555	3
O	1555	1556	.
O	1556	1558	32
O	1559	1560	×
O	1561	1563	10
O	1563	1564	-
O	1564	1566	10
O	1566	1567	)
O	1567	1568	.

O	1569	1572	The
O	1573	1585	associations
O	1586	1590	were
O	1591	1598	similar
O	1599	1602	for
O	1603	1607	both
B-outcome	1608	1621	premenopausal
O	1622	1623	(
O	1623	1625	OR
O	1628	1629	=
O	1632	1633	0
O	1633	1634	.
O	1634	1636	44
O	1636	1637	,
O	1638	1640	95
O	1640	1641	%
O	1642	1644	CI
O	1644	1645	:
O	1645	1646	0
O	1646	1647	.
O	1647	1649	31
O	1649	1650	-
O	1650	1651	0
O	1651	1652	.
O	1652	1654	62
O	1654	1655	,
O	1656	1657	p
O	1659	1660	=
O	1662	1663	9
O	1663	1664	.
O	1664	1666	91
O	1667	1668	×
O	1669	1671	10
O	1671	1672	-
O	1672	1673	8
O	1673	1674	)
O	1675	1678	and
B-outcome	1679	1693	postmenopausal
I-outcome	1694	1700	breast
I-outcome	1701	1707	cancer
O	1708	1709	(
O	1709	1711	OR
O	1713	1714	=
O	1716	1717	0
O	1717	1718	.
O	1718	1720	57
O	1720	1721	,
O	1722	1724	95
O	1724	1725	%
O	1726	1728	CI
O	1728	1729	:
O	1730	1731	0
O	1731	1732	.
O	1732	1734	46
O	1734	1735	-
O	1735	1736	0
O	1736	1737	.
O	1737	1739	71
O	1739	1740	,
O	1741	1742	p
O	1744	1745	=
O	1747	1748	1
O	1748	1749	.
O	1749	1751	88
O	1752	1753	×
O	1754	1756	10
O	1756	1757	-
O	1757	1758	8
O	1758	1759	)
O	1759	1760	.

O	1761	1765	This
O	1766	1777	association
O	1778	1781	was
O	1782	1792	replicated
O	1793	1795	in
O	1796	1799	the
O	1800	1804	data
O	1805	1809	from
O	1810	1813	the
O	1814	1819	DRIVE
O	1820	1830	consortium
O	1831	1832	(
O	1832	1834	OR
O	1836	1837	=
O	1839	1840	0
O	1840	1841	.
O	1841	1843	72
O	1843	1844	,
O	1845	1847	95
O	1847	1848	%
O	1849	1851	CI
O	1851	1852	:
O	1853	1854	0
O	1854	1855	.
O	1855	1857	60
O	1857	1858	-
O	1858	1859	0
O	1859	1860	.
O	1860	1862	84
O	1862	1863	,
O	1864	1865	p
O	1868	1869	=
O	1872	1873	1
O	1873	1874	.
O	1874	1876	64
O	1877	1878	×
O	1879	1881	10
O	1881	1882	-
O	1882	1883	7
O	1883	1884	)
O	1884	1885	.

O	1886	1892	Single
O	1893	1899	marker
O	1900	1908	analyses
O	1909	1919	identified
O	1920	1922	17
O	1923	1925	of
O	1926	1929	the
O	1930	1932	84
O	1933	1936	BMI
O	1936	1937	-
O	1937	1947	associated
O	1948	1954	single
O	1955	1965	nucleotide
O	1966	1979	polymorphisms
O	1980	1981	(
O	1981	1985	SNPs
O	1985	1986	)
O	1987	1989	in
O	1990	2001	association
O	2002	2006	with
B-outcome	2007	2013	breast
I-outcome	2014	2020	cancer
I-outcome	2021	2025	risk
O	2026	2028	at
O	2029	2030	p
O	2031	2032	<
O	2033	2034	0
O	2034	2035	.
O	2035	2037	05
O	2037	2038	;
O	2039	2042	for
O	2043	2045	16
O	2046	2048	of
O	2049	2053	them
O	2053	2054	,
O	2055	2058	the
O	2059	2065	allele
O	2066	2076	associated
O	2077	2081	with
O	2082	2090	elevated
O	2091	2094	BMI
O	2095	2098	was
O	2099	2109	associated
O	2110	2114	with
O	2115	2122	reduced
O	2123	2129	breast
O	2130	2136	cancer
O	2137	2141	risk
O	2141	2142	.

O	2143	2146	BMI
O	2147	2156	predicted
O	2157	2159	by
O	2160	2166	genome
O	2166	2167	-
O	2167	2171	wide
O	2172	2183	association
O	2184	2191	studies
O	2192	2193	(
O	2193	2197	GWAS
O	2197	2198	)
O	2198	2199	-
O	2199	2209	identified
O	2210	2218	variants
O	2219	2221	is
O	2222	2231	inversely
O	2232	2242	associated
O	2243	2247	with
O	2248	2251	the
O	2252	2256	risk
O	2257	2259	of
O	2260	2264	both
O	2265	2268	pre
O	2268	2269	-
O	2270	2273	and
O	2274	2288	postmenopausal
O	2289	2295	breast
O	2296	2302	cancer
O	2302	2303	.

O	2304	2307	The
O	2308	2315	reduced
O	2316	2320	risk
O	2321	2323	of
O	2324	2338	postmenopausal
O	2339	2345	breast
O	2346	2352	cancer
O	2353	2363	associated
O	2364	2368	with
O	2369	2380	genetically
O	2381	2390	predicted
O	2391	2394	BMI
O	2395	2403	observed
O	2404	2406	in
O	2407	2411	this
O	2412	2417	study
O	2418	2425	differs
O	2426	2430	from
O	2431	2434	the
O	2435	2443	positive
O	2444	2455	association
O	2456	2464	reported
O	2465	2469	from
O	2470	2477	studies
O	2478	2483	using
O	2484	2492	measured
O	2493	2498	adult
O	2499	2502	BMI
O	2502	2503	.

O	2504	2517	Understanding
O	2518	2521	the
O	2522	2529	reasons
O	2530	2533	for
O	2534	2538	this
O	2539	2550	discrepancy
O	2551	2554	may
O	2555	2561	reveal
O	2562	2570	insights
O	2571	2575	into
O	2576	2579	the
O	2580	2587	complex
O	2588	2600	relationship
O	2601	2603	of
O	2604	2611	genetic
O	2612	2624	determinants
O	2625	2627	of
O	2628	2632	body
O	2633	2639	weight
O	2640	2642	in
O	2643	2646	the
O	2647	2655	etiology
O	2656	2658	of
O	2659	2665	breast
O	2666	2672	cancer
O	2672	2673	.
